We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$21.8B
AUM Growth
-$767M
Cap. Flow
+$148M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.44%
Holding
1,924
New
62
Increased
766
Reduced
660
Closed
101

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$77.8M
2
TREX icon
Trex
TREX
+$39.7M
3
DOCU
DocuSign
DOCU
+$17.2M
4
AKAM icon
Akamai
AKAM
+$16.6M
5
GLD icon
SPDR Gold Trust
GLD
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 23.15%
2 Healthcare 19.33%
3 Financials 11.9%
4 Industrials 11.25%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
51
Amphenol
APH
$210B
$102M 0.47%
3,033,584
-14,550
-0.5% -$528K
XMTR icon
52
Xometry
XMTR
$5.34B
$101M 0.46%
1,773,755
+68,597
+4% +$3.2M
LLY icon
53
Eli Lilly
LLY
$1.09T
$98.8M 0.45%
305,689
+10,877
+4% +$3.45M
BX icon
54
Blackstone
BX
$110B
$98.4M 0.45%
1,176,068
+74,576
+7% +$7.22M
WMT icon
55
Walmart Inc
WMT
$923B
$95.4M 0.44%
2,206,323
-339
-0% -$14.8K
EW icon
56
Edwards Lifesciences
EW
$53.6B
$94.3M 0.43%
1,141,681
+189
+0% +$18.2K
CVX icon
57
Chevron
CVX
$386B
$94.1M 0.43%
654,660
+28,690
+5% +$4.38M
RYAN icon
58
Ryan Specialty Holdings
RYAN
$11B
$92.4M 0.42%
2,273,960
+71,219
+3% +$3.01M
VIG icon
59
Vanguard Dividend Appreciation ETF
VIG
$115B
$92.1M 0.42%
681,122
-27,271
-4% -$4.06M
KMX icon
60
CarMax
KMX
$8.33B
$91.8M 0.42%
1,390,387
-50,738
-4% -$4.64M
TDG icon
61
TransDigm Group
TDG
$68.3B
$91.4M 0.42%
174,135
-1,423
-0.8% -$849K
BMY icon
62
Bristol-Myers Squibb
BMY
$130B
$90.7M 0.42%
1,275,263
+15,960
+1% +$1.16M
BRK.B icon
63
Berkshire Hathaway Class B
BRK.B
$1.09T
$89.7M 0.41%
335,919
+9,580
+3% +$2.73M
AME icon
64
Ametek
AME
$59.3B
$85.3M 0.39%
751,827
-5,538
-0.7% -$664K
ITW icon
65
Illinois Tool Works
ITW
$83.3B
$84.9M 0.39%
469,996
+16,062
+4% +$3.17M
EVH icon
66
Evolent Health
EVH
$471M
$84.5M 0.39%
2,352,580
+23,645
+1% +$833K
DIS icon
67
Walt Disney
DIS
$178B
$83.9M 0.39%
889,556
-7,705
-0.9% -$825K
AXP icon
68
American Express
AXP
$232B
$82.8M 0.38%
613,957
+17,194
+3% +$2.6M
TMO icon
69
Thermo Fisher Scientific
TMO
$223B
$80.8M 0.37%
159,221
+2,474
+2% +$1.38M
MCD icon
70
McDonald's
MCD
$195B
$79M 0.36%
342,512
+10,998
+3% +$2.81M
PEP icon
71
PepsiCo
PEP
$189B
$78.3M 0.36%
479,743
+5,307
+1% +$915K
P
72
Everpure Inc
P
$37B
$77.4M 0.36%
2,829,218
-20,740
-0.7% -$586K
VEA icon
73
Vanguard FTSE Developed Markets ETF
VEA
$238B
$77.1M 0.35%
2,121,146
+28,469
+1% +$1.16M
VRSK icon
74
Verisk Analytics
VRSK
$23.5B
$75M 0.34%
439,707
+856
+0.2% +$160K
PODD icon
75
Insulet
PODD
$10.1B
$74.3M 0.34%
323,797
+15,959
+5% +$4M

Similar funds

William Blair & Company's Q3 2022 Portfolio in Review

As of Q3 2022, William Blair & Company held 1,924 positions worth $21.8B, down 3.4% from $22.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

William Blair & Company's Q3 2022 filing shows 62 new, 766 increased, 660 reduced and 101 closed positions. Its largest new stake was GSK: 37,792 shares worth $1.11M. The largest sale was Atlassian, an estimated $77.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q3 2022 buy was GSK: 37,792 shares worth $1.11M.
  • William Blair & Company added most to Watsco Inc in Q3 2022, an estimated $31.3M increase.
  • William Blair & Company's biggest Q3 2022 reduction was Trex, cutting an estimated $39.7M.
  • William Blair & Company fully exited Atlassian in Q3 2022, selling an estimated $77.8M.
  • William Blair & Company's ten largest holdings make up 23% of its $21.8B portfolio in Q3 2022.
  • William Blair & Company opened 62 new positions and closed 101 in Q3 2022.
  • William Blair & Company's portfolio value fell 3.4% quarter-over-quarter to $21.8B.

Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.